title: Assessment of different transfection parameters in efficiency optimization.
abstract: Achieving optimal transfection efficiency is the most critical step in overcoming the primary obstacle to success in nonviral-mediated gene therapy. Several transfection parameters were being examined including the effects of different types of transfection media, glucose concentration, reporter DNA concentration, and incubation time in lipotransfectant. Efficiency of transfection obtained was highest for Opti-MEM I (29 +/- 2.28%; p = 0.001) followed by M199 (24 +/- 1.54%; p = 0.009), both of which performed significantly better than DMEM (14 +/- 0.28%) as a transfection medium. The rate of transfection was affected by glucose levels in only DMEM with higher efficiency achieved using low glucose containing DMEM (17 +/- 0.38%) than its counterpart. Furthermore, transfection rate and cell viability were severely hampered by lengthened exposure to transfection complexes, leading to an overall mean efficiency of 5 +/- 0.87%. However, doubling the DNA content in the transfection mixture did not significantly change the mean rate of transfection in M199 medium (24 +/- 1.54% to 27 +/- 1.54%; p = 0.273). The overall range of mean efficiency acquired with our protocol under different transfection conditions was between 14% and 29%. Hopefully results from this study will further potential success in nonviral-mediated gene transfer.
authors.affiliation: Department of Surgery, Surgical-Medical Research Institute, University of Alberta, Edmonton, Canada T6G 2N8.
authors.forename: A T L
authors.initials: AT
authors.lastname: Young
authors.forename: R B
authors.initials: RB
authors.lastname: Moore
authors.forename: A G
authors.initials: AG
authors.lastname: Murray
authors.forename: J C
authors.initials: JC
authors.lastname: Mullen
authors.forename: J R T
authors.initials: JR
authors.lastname: Lakey
mesh_terms: D002478:Cells, Cultured; D004247:DNA / Q000737:chemistry; D042783:Endothelial Cells; D015870:Gene Expression; D017930:Genes, Reporter / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D008081:Liposomes; D008164:Luminescent Proteins / Q000235:genetics; D014162:Transfection / Q000379:methods*; D014471:Umbilical Veins / Q000166:cytology
chemical_list: D008081:Liposomes; D008164:Luminescent Proteins; D004247:DNA